Efavirenz induces a striking and generalized increase of HDL-cholesterol in HIV-infected patients.

Eugenia Negredo, Josep Ribalta, Raimon Ferré, Juliana Salazar, Celestino Rey-Joly, Guillem Sirera, Lluís Masana, Bonaventura Clotet

Journal: AIDS (London, England) 2004;18(5):819-21

PMID: 15075521

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

DOI: 10.1097/00002030-200403260-00017

Link outs

Free resources

Medical:

https://medlineplus.gov/hivinwomen.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Adult, Alkynes, Antiretroviral Therapy, Highly Active, Benzoxazines, Cholesterol, HDL, Cyclopropanes, Didanosine, Female, HIV Infections, HIV Protease Inhibitors, HIV-1, Humans, Lipids, Lipoproteins, Magnetic Resonance Spectroscopy, Male, Multivariate Analysis, Oxazines, Reverse Transcriptase Inhibitors, Stavudine

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.